📰 Webs News
Page 18 - Webs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Webs. Real-time updates on events, politics, business and more.
May 25, 2023
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received a consensus recommendation of “Hold” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and two have given a buy recommendation to the company. […]
May 25, 2023
Prescott Group Capital Management L.L.C. purchased a new position in Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 91,000 shares of the biopharmaceutical company’s stock, valued at approximately $1,075,000. Prescott Group Capital Management L.L.C. […]
May 22, 2023
Chemical metrology helps to combat food fraud and ensure food authenticity and traceability.
May 22, 2023
Alarm.com Holdings, Inc. (ALRM), an IoT solution provider, announced on Monday that it has acquired EBS, a Polish security communicator manufacturer. Financial terms of the deal are not yet known.
May 22, 2023
StockNews.com initiated coverage on shares of Emergent BioSolutions (NYSE:EBS – Get Rating) in a report released on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Benchmark upgraded Emergent BioSolutions from a hold rating to a buy rating and […]
May 10, 2023
Emergent BioSolutions (NYSE:EBS – Get Rating) announced its earnings results on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. Emergent BioSolutions had a negative net margin of 19.97% and a negative return on equity of 7.57%. The firm had revenue of $165.10 million […]
May 10, 2023
Emergent BioSolutions (NYSE:EBS – Get Rating) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. The business had revenue of $165.10 million during the quarter, compared to analyst estimates of $142.85 million. Emergent BioSolutions had a negative net […]
May 10, 2023
Emergent BioSolutions (NYSE:EBS – Get Rating) released its earnings results on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. The business had revenue of $165.10 million during the quarter, compared to analyst estimates of $142.85 million. Emergent BioSolutions had a negative net margin […]
May 3, 2023
Aaron Rodriguez, a leading eCommerce expert, has revealed the power of ChatGPT in revolutionizing retail and e-commerce SEO for unprecedented success., , , , SEO is critical to the success of any e-commerce business, as it enables businesses to drive traffic to their website and increase their visibility online. ChatGPT, a large language model trained by OpenAI, based on the GPT-3.5 architecture, is a powerful tool that can help businesses improve their SEO and drive more traffic to their webs....
May 2, 2023
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 7,190,000 shares, a decline of 5.4% from the March 31st total of 7,600,000 shares. Based on an average trading volume of 1,720,000 shares, the short-interest ratio is […]